Page last updated: 2024-10-22

alosetron and Cancer of Intestines

alosetron has been researched along with Cancer of Intestines in 1 studies

alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"In 27 patients with carcinoid diarrhoea, symptoms were recorded daily and gastrointestinal transit was measured by scintigraphy in a three dose (0."2.69Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea. ( Burton, DD; Camilleri, M; Forstrom, LA; Pitot, HC; Rubin, J; Saslow, SB; Scolapio, JS; Thomforde, GM; Zinsmeister, AR, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saslow, SB1
Scolapio, JS1
Camilleri, M1
Forstrom, LA1
Thomforde, GM1
Burton, DD1
Rubin, J1
Pitot, HC1
Zinsmeister, AR1

Trials

1 trial available for alosetron and Cancer of Intestines

ArticleYear
Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea.
    Gut, 1998, Volume: 42, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Carbolines; Carcinoid Tumor; Colon; Diarrhea; Double-Blind Method; D

1998